BR9408077A - Enzimas de conversão de endotelina seqências de dna, processos para a obtenção por técnicas genéticas, de enzimas de conversão de endotelina substâncias inhibidoras para enzimas de conversão de endotelina e para a prepação de medicamentos que inibem uma enzima de conversão de endotelina e aplicações da enzima de conversão de endotelina das substâncias inibidoras de anticorpos de uma sequência de dna e de sequências parciais - Google Patents

Enzimas de conversão de endotelina seqências de dna, processos para a obtenção por técnicas genéticas, de enzimas de conversão de endotelina substâncias inhibidoras para enzimas de conversão de endotelina e para a prepação de medicamentos que inibem uma enzima de conversão de endotelina e aplicações da enzima de conversão de endotelina das substâncias inibidoras de anticorpos de uma sequência de dna e de sequências parciais

Info

Publication number
BR9408077A
BR9408077A BR9408077A BR9408077A BR9408077A BR 9408077 A BR9408077 A BR 9408077A BR 9408077 A BR9408077 A BR 9408077A BR 9408077 A BR9408077 A BR 9408077A BR 9408077 A BR9408077 A BR 9408077A
Authority
BR
Brazil
Prior art keywords
endothelin
enzymes
enzyme
conversion
inhibiting substances
Prior art date
Application number
BR9408077A
Other languages
English (en)
Inventor
Burkhard Kroeger
Harald Seulberger
Thomas Meyer
Martin Schmidt
Elard Jacob
Rainer Otter
Thomas Subkowski
Heinz Hillen
Original Assignee
Basf Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934339100 external-priority patent/DE4339100A1/de
Priority claimed from DE19944403665 external-priority patent/DE4403665A1/de
Priority claimed from DE19944412372 external-priority patent/DE4412372A1/de
Application filed by Basf Corp filed Critical Basf Corp
Publication of BR9408077A publication Critical patent/BR9408077A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • C12N9/6497Endothelin-converting enzyme (3.4.24.71)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24071Endothelin-converting enzyme 1 (3.4.24.71)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
BR9408077A 1993-11-16 1994-11-10 Enzimas de conversão de endotelina seqências de dna, processos para a obtenção por técnicas genéticas, de enzimas de conversão de endotelina substâncias inhibidoras para enzimas de conversão de endotelina e para a prepação de medicamentos que inibem uma enzima de conversão de endotelina e aplicações da enzima de conversão de endotelina das substâncias inibidoras de anticorpos de uma sequência de dna e de sequências parciais BR9408077A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19934339100 DE4339100A1 (de) 1993-11-16 1993-11-16 Endothelinkonversionsenzym-1 (ECE-1)
DE19944403665 DE4403665A1 (de) 1994-02-07 1994-02-07 Endothelinkonversionsenzym (ECE)
DE19944412372 DE4412372A1 (de) 1994-04-12 1994-04-12 Endothelinkonversionsenzym (ECE)
PCT/EP1994/003706 WO1995014095A1 (de) 1993-11-16 1994-11-10 Endothelinkonversionsenzym (ece)

Publications (1)

Publication Number Publication Date
BR9408077A true BR9408077A (pt) 1997-08-12

Family

ID=27205762

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9408077A BR9408077A (pt) 1993-11-16 1994-11-10 Enzimas de conversão de endotelina seqências de dna, processos para a obtenção por técnicas genéticas, de enzimas de conversão de endotelina substâncias inhibidoras para enzimas de conversão de endotelina e para a prepação de medicamentos que inibem uma enzima de conversão de endotelina e aplicações da enzima de conversão de endotelina das substâncias inibidoras de anticorpos de uma sequência de dna e de sequências parciais

Country Status (18)

Country Link
US (1) US6066502A (pt)
EP (1) EP0728209B1 (pt)
JP (1) JPH09505733A (pt)
KR (1) KR960705934A (pt)
CN (1) CN1141651A (pt)
AT (1) ATE315656T1 (pt)
AU (1) AU8107094A (pt)
BR (1) BR9408077A (pt)
CA (1) CA2176507A1 (pt)
CZ (1) CZ139496A3 (pt)
DE (1) DE59410427D1 (pt)
FI (1) FI962047A (pt)
HU (1) HUT75554A (pt)
NO (1) NO962023L (pt)
NZ (1) NZ275817A (pt)
PL (1) PL314480A1 (pt)
SK (1) SK59896A3 (pt)
WO (1) WO1995014095A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6255468B1 (en) * 1998-05-07 2001-07-03 Smithkline Beecham Plc MPROT12 polynucleotides and methods thereof
EP1409690A2 (en) 1999-09-24 2004-04-21 Lexicon Genetics Incorporated Human endothelin converting enzyme-like proteins and polynucleotides encoding the same
DE502004000540D1 (de) * 2004-02-13 2006-06-14 Brahms Ag Verfahren zur Bestimmung der Bildung von Endothelinen zu Zwecken der medizinischen Diagnostik, sowie Antikörper und Kits für die Durchführung eines solchen Verfahrens
WO2009018209A1 (en) 2007-07-27 2009-02-05 The Regents Of The University Of Colorado, A Body Corporate ENDOTHELIN SINGLE NUCLEOTIDE POLYMORPHISMS AND METHODS OF PREDICTING β-ADRENERGIC RECEPTOR TARGETING AGENT EFFICACY

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2966939B2 (ja) * 1990-12-07 1999-10-25 日清製粉株式会社 ヒト細胞由来のエンドセリン変換酵素
EP0575405A1 (en) * 1991-02-04 1993-12-29 Berlex Laboratories, Inc. Endothelin converting enzyme

Also Published As

Publication number Publication date
KR960705934A (ko) 1996-11-08
WO1995014095A1 (de) 1995-05-26
CA2176507A1 (en) 1995-05-26
DE59410427D1 (en) 2006-04-06
CZ139496A3 (en) 1997-10-15
EP0728209B1 (de) 2006-01-11
ATE315656T1 (de) 2006-02-15
AU8107094A (en) 1995-06-06
JPH09505733A (ja) 1997-06-10
NO962023L (no) 1996-07-16
NO962023D0 (no) 1996-05-15
CN1141651A (zh) 1997-01-29
SK59896A3 (en) 1997-07-09
US6066502A (en) 2000-05-23
NZ275817A (en) 1997-02-24
HUT75554A (en) 1997-05-28
PL314480A1 (en) 1996-09-16
HU9601298D0 (en) 1996-07-29
FI962047A (fi) 1996-07-12
FI962047A0 (fi) 1996-05-14
EP0728209A1 (de) 1996-08-28

Similar Documents

Publication Publication Date Title
AU4634396A (en) Dna sequences encoding carbohydrate polymer synthesizing enzymes and method for producing transgenic plants
WO1994001548A3 (en) Human nucleic acid fragments, isolated from brain adrenal tissue, placenta or bone narrow
AU4526193A (en) Binding competent oligomers containing 2', 5' linkages
BR9814276A (pt) Antìgenos de superfìcie
WO1993016099A3 (en) Dna sequences encoding novel growth/differentiation factors
AU1672388A (en) Expression of human proapolipoprotein a-i
BR9712402A (pt) Novas toxinas pesticidas e sequencias de nucleotídeos que codificam essas toxina
IL135687A0 (en) A novel human checkpoint kinase, hcds1, compositions and methods
AU2633497A (en) Peptides having antiproliferative properties
AU7617796A (en) Variants of human recombinant interferon-gamma (rhu-ifn-gamma) having increased heat-stability
DK0418945T3 (da) Forgreningsenzym og dets anvendelse
BR9408077A (pt) Enzimas de conversão de endotelina seqências de dna, processos para a obtenção por técnicas genéticas, de enzimas de conversão de endotelina substâncias inhibidoras para enzimas de conversão de endotelina e para a prepação de medicamentos que inibem uma enzima de conversão de endotelina e aplicações da enzima de conversão de endotelina das substâncias inibidoras de anticorpos de uma sequência de dna e de sequências parciais
PT811071E (pt) Sequencias amolificadas derivadas do gene da desmina vectores que compreendem estas sequencias e suas utilizacoes para a producao de proteinas
IL116026A (en) Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses
WO1999028439A3 (fr) Erythrovirus et ses applications
WO1997044454A3 (en) Human phospholipase inhibitor
DE69318716D1 (de) Anti-Katze Immundefiziensvirus (FIV) Impfstoffe
PE20000759A1 (es) Gen de la citocroma oxidasa de hidroquinona del tipo bd
NZ332586A (en) Suppression of endogenous gene and replacement of suppressed gene sequence
FI955286A (fi) Brevibacterium Sterolicumista peräisin oleva kolesterolioksidaasi
WO2000024765A8 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
HUP0002231A2 (hu) Porc oligomer mátrix fehérje alkalmazása reumatoid arthritis kezelésére
WO1999054446A3 (de) Menschliche nukleinsäuresequenzen, die in pankreasnormalgewebe überexprimiert sind
AU2001287860A1 (en) Transglutaminase gene products
WO2000032794A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof

Legal Events

Date Code Title Description
FA Application withdrawn